Literature DB >> 24599890

The rise of new psychoactive substance use in Australia.

Lucy Burns1, Amanda Roxburgh, Allison Matthews, Raimondo Bruno, Simon Lenton, Joe Van Buskirk.   

Abstract

New Psychoactive Substances are now a feature of Australia's recreational drug market. Little is known, however, about the prevalence of use, the characteristics of people who use them and the relationship between the NPS and ecstasy markets. This study examined the prevalence and correlates of NPS use amongst a group of regular ecstasy users in Australia. Participants were recruited if they had used ecstasy at least six times in the previous six months, lived in a capital city and were over 16 years of age. Purposive sampling was used, recruiting through universities and colleges, word of mouth and street press. 654 participants were recruited in 2013. Respondents who had used an NPS in the past six months were compared to those who had not. NPS were used by 44% of the total sample. In 2013 2C-I (14%) and 2C-B (8%) were the most prevalent NPS. Respondents in the NPS group were younger and reported more frequent use of more types of drugs. They were also more likely to rate the purity of ecstasy as low relative to those in the no NPS group. NPS are now an established part of Australia's recreational drug scene and NPS with hallucinogenic effects are now used most commonly. Monitoring systems need to develop capacity to monitor this highly dynamic market.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ecstasy; new psychoactive substances; prevalence

Mesh:

Substances:

Year:  2014        PMID: 24599890     DOI: 10.1002/dta.1626

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  5 in total

1.  Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.

Authors:  Joseph J Palamar; Patricia Acosta; Danielle C Ompad; Charles M Cleland
Journal:  Subst Use Misuse       Date:  2016-09-23       Impact factor: 2.164

2.  Assessing self-reported use of new psychoactive substances: The impact of gate questions.

Authors:  Joseph J Palamar; Patricia Acosta; Fermín Fernández Calderón; Scott Sherman; Charles M Cleland
Journal:  Am J Drug Alcohol Abuse       Date:  2017-05-09       Impact factor: 3.829

3.  Acute Pharmacological Effects of 2C-B in Humans: An Observational Study.

Authors:  Esther Papaseit; Magí Farré; Clara Pérez-Mañá; Marta Torrens; Mireia Ventura; Mitona Pujadas; Rafael de la Torre; Débora González
Journal:  Front Pharmacol       Date:  2018-03-13       Impact factor: 5.810

4.  Awareness survey of so-called Dappou drugs or Kiken drugs (New Psychoactive Substances) among University Students in Japan.

Authors:  Yasuko Fuse-Nagase; Fukumi Saito; Toshie Hirohara; Happei Miyakawa
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-10-09

5.  Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions.

Authors:  Débora González; Marta Torrens; Magí Farré
Journal:  Biomed Res Int       Date:  2015-10-12       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.